MDxHealth (MDXH) said Monday it expects Q4 revenue to increase by 28% year over year to about $24.7 million.
Five analysts polled by FactSet expect $23 million.
For 2024, the company also projected a 28% revenue growth to $90 million. Analysts surveyed by FactSet expect $87.9 million.
In addition, MDxHealth said it expects 2025 revenue growth of 20% to 22% to between $108 million and $110 million and reiterated its forecast of adjusted EBITDA profitability in H1.
Shares of MDxHealth were up more than 10% in recent premarket activity Monday.
Price: 2.18, Change: +0.20, Percent Change: +10.10
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。